Both in Biotechnology
Taysha Gene Therapies vs BioCryst Pharmaceuticals
Over the past year TSHA returned −23.3% and BCRX returned +12.4%; their daily moves had a correlation of 0.31.
TSHA −23.3% BCRX +12.4%Growth of $1, one year, split-adjusted
| Metric | TSHA | BCRX |
|---|---|---|
| Price | $3.62 | $7.79 |
| Market cap | $1.18B | $1.99B |
| Today | −2.95% | −2.87% |
| 1 month | −29.8% | −10.5% |
| 6 months | −43.7% | −18.0% |
| Year to date | −34.2% | −0.1% |
| 1 year | −32.2% | +14.4% |
| Revenue growth (YoY) | −100.0% | +33.6% |
| Gross margin | — | 98.2% |
| Net margin | — | 35.9% |
| P/E (TTM) | — | — |
| Price / sales | 215.0× | 2.1× |
| Net cash | $406.1M | -$471.6M |
| Dividend yield | — | — |
| Volatility (60d) | 57.8% | 44.6% |
| Short % of float | 18.9% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).